NervGen Pharma

NGEN

1.6352.83% ( +0.045 )

Trading: Jul 30, 14:21:18 (EDT)

Financial report interval: 2025.12.31 - 2026.03.31

Preview: NervGen Pharma(NGEN) predict that the EBIT is -5.407 M (--%), Beat estimate;the EPS is -0.0469 (-56.82%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

TBA--

0.00B--

----

EBITExceed expectations

-0.01B--

+0.00B--%

EPSExceed expectations

-0.046956.82%

-0.048561.86%

+0.00165.04%

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD